TCL Archive In Brief: ACCC to Bid On Ovarian Cancer Treatment RFP; Community MDs Handle 90% Of Ovarian Patients September 5, 1975
TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment December 29, 2006